Active Biotech (Sweden) Technical Analysis
| ACTI Stock | SEK 0.04 0.0002 0.48% |
As of the 3rd of February, Active Biotech shows the Mean Deviation of 2.8, risk adjusted performance of (0.15), and Standard Deviation of 4.28. Active Biotech AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Active Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Active, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ActiveActive |
Active Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Active Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Active Biotech.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Active Biotech on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Active Biotech AB or generate 0.0% return on investment in Active Biotech over 90 days. Active Biotech is related to or competes with Biovica International, NextCell Pharma, Pila Pharma, Nanologica, Iconovo, Sprint Bioscience, and Biosergen. Active Biotech AB , a biotechnology company, develops drugs for the treatment of neurodegenerative diseases, autoimmunit... More
Active Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Active Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Active Biotech AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 23.2 | |||
| Value At Risk | (7.26) | |||
| Potential Upside | 5.89 |
Active Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Active Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Active Biotech's standard deviation. In reality, there are many statistical measures that can use Active Biotech historical prices to predict the future Active Biotech's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (0.95) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | (0.93) |
Active Biotech February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.15) | |||
| Market Risk Adjusted Performance | (0.92) | |||
| Mean Deviation | 2.8 | |||
| Coefficient Of Variation | (477.03) | |||
| Standard Deviation | 4.28 | |||
| Variance | 18.31 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (0.95) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | (0.93) | |||
| Maximum Drawdown | 23.2 | |||
| Value At Risk | (7.26) | |||
| Potential Upside | 5.89 | |||
| Skewness | (1.04) | |||
| Kurtosis | 4.73 |
Active Biotech AB Backtested Returns
Active Biotech AB secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the company had a -0.23 % return per unit of risk over the last 3 months. Active Biotech AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Active Biotech's Risk Adjusted Performance of (0.15), standard deviation of 4.28, and Mean Deviation of 2.8 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.98, which signifies possible diversification benefits within a given portfolio. Active Biotech returns are very sensitive to returns on the market. As the market goes up or down, Active Biotech is expected to follow. At this point, Active Biotech AB has a negative expected return of -1.01%. Please make sure to confirm Active Biotech's maximum drawdown, potential upside, kurtosis, as well as the relationship between the value at risk and skewness , to decide if Active Biotech AB performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.62 |
Good predictability
Active Biotech AB has good predictability. Overlapping area represents the amount of predictability between Active Biotech time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Active Biotech AB price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current Active Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.62 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Active Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Active Biotech AB Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Active Biotech AB across different markets.
About Active Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Active Biotech AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Active Biotech AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Active Biotech AB price pattern first instead of the macroeconomic environment surrounding Active Biotech AB. By analyzing Active Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Active Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Active Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
Active Biotech February 3, 2026 Technical Indicators
Most technical analysis of Active help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Active from various momentum indicators to cycle indicators. When you analyze Active charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.15) | |||
| Market Risk Adjusted Performance | (0.92) | |||
| Mean Deviation | 2.8 | |||
| Coefficient Of Variation | (477.03) | |||
| Standard Deviation | 4.28 | |||
| Variance | 18.31 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (0.95) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | (0.93) | |||
| Maximum Drawdown | 23.2 | |||
| Value At Risk | (7.26) | |||
| Potential Upside | 5.89 | |||
| Skewness | (1.04) | |||
| Kurtosis | 4.73 |
Active Biotech February 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Active stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 248,032 | ||
| Daily Balance Of Power | (0.10) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 0.04 | ||
| Day Typical Price | 0.04 | ||
| Price Action Indicator | 0.00 |
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.